Acquisition

Quipt Home Medical's acquisition by private equity offers a massive premium to shareholders and sets the stage for aggressive M&A in the home respiratory care market.

Natera's legal retreat solidifies a major victory for NeoGenomics, clearing the runway for its RaDaR ST launch and shaking the diagnostic patent landscape.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.

Vanda Pharmaceuticals submits its novel GPP therapy, imsidolimab, for FDA review, offering new hope for patients and bolstering its rare disease portfolio.

A moving company hosts a governor, revealing the complex logistics and infrastructure network profiting from America's massive wealth redistribution.

Palantir's DGSI contract renewal isn't just a deal; it's a story of strategic reliance, political tension, and the bedrock of its business model.

As Sinch appoints Lindy Puttkammer as its new CHRO, the move signals a deep focus on integrating its global workforce and nurturing talent from within.

Coldwell Banker India appoints a decade-long partner as Area Developer for four southern states, a strategic move to dominate the region's booming market.

The infrastructure giant's new €800M share repurchase isn't just for shareholder value; it's a strategic move to fund future growth and acquisitions.

The junior explorer is expanding its footprint in a hot gold district. We analyze the financial mechanics, shareholder impact, and leadership incentives.

The media giant is refinancing high-cost debt to fund acquisitions and tech. Is this a savvy move to secure its future or a risky balance sheet gamble?

AIP Realty Trust's $78.7M acquisition of AllTrades pivots on a complex related-party deal and reverse takeover, putting unitholder trust to the test.

Clairvest's successful exit from F12.net yields a 35% IRR, showcasing a powerful growth strategy for private equity in Canada's booming MSP market.

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

Huntington Bank opens a South Euclid branch, blending community focus with an aggressive M&A strategy aiming to make it a top 10 U.S. bank.

Alamo Group's acquisition of Petersen Industries for $166.5M isn't just another deal. It's a strategic move to dominate the waste management equipment market.

A top industrial firm offers a surprising blueprint for fixing healthcare's biggest challenges, from clinician burnout to supply chain woes.

Amid a $2.37B buyout, Weiss Asset Management's increased stake in Avadel Pharma raises questions. Is it a vote of confidence or a strategic power play?

Hedge fund Balyasny Asset Management builds a 1.72% stake in JTC plc, signaling high-stakes maneuvering in the £2.3 billion takeover saga.